Back to feed
SOPHSOPHiA GENETICS SA
CIK 0001840706 · last filing 2d ago · 2 insider transactions
Buy volume
$0
0 buy transactions
Sell volume
$65.8K
2 sell transactions
Net flow
-$65.8K
Net selling
Total flow
$65.8K
2 priced transactions
Disclosure radarcross-source convergence
Institution-led3/5 sources
8/100
Recent disclosures · timeline
- Form 42d ago
Chief Technology Officer · sold $38.2K
- Form 42d ago
Chief Medical Officer · sold $27.5K
- Form 1442d ago
Proposed sale of 68,129 sh ($387.7K) · discretionary
- Form 1443d ago
Proposed sale of 1,373 sh ($7.6K) · discretionary
Price · SOPH
Live chart by TradingViewLive chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
SOPH insider flow· last 30 days
Buys Sellsnet -$65.8K
Institutional holders · 13F
Q1 2026 vs Q4 2025 · live SEC data4 funds hold$421.9K reported valueNet reducing(1 adding · 2 reducing)
| Fund | Shares | Value | % of portfolio | QoQ |
|---|---|---|---|---|
| Renaissance Technologies LLC Jim Simons (founder) | 59,800 | $296.0K | 0.0% | Trim-28% |
| Two Sigma Investments LP | 10,198 | $50.5K | 0.0% | New |
| Millennium Management LLC | 10,142 | $50.2K | 0.0% |
Proposed sales · Form 144
selling intent · live SEC data2 notices$395.2K proposed to sell0/2 under a 10b5-1 plan
| Filed | Filer | Shares | Est. value | Approx. sale | Source of shares | Plan |
|---|---|---|---|---|---|---|
| 2d ago | JURGI CAMBLONG Director, Officer | 68,129 | $387.7K | Jun 26, 2026 | Founders Shares | Discretionary |
| 3d ago | JURGI CAMBLONG Director, Officer | 1,373 | $7.6K | Jun 25, 2026 | Founders Shares | Discretionary |
Recent insider transactions
| Filed | Insider | Transaction | Shares | Price | Value | Signal | Flags | |
|---|---|---|---|---|---|---|---|---|
2d ago Jun 25, 2026 | Verma Abhimanyu Chief Technology Officer | Sell · S | 6,944 | $5.51 | $38.2K | Neutral-7 | ||
2d ago Jun 25, 2026 | Menu Philippe Chief Medical Officer | Sell · S | 5,000 | $5.50 | $27.5K | Neutral-7 |